Wegovy FlexTouch Pen

Plain, Discreet
Packaging
Tracked 24*7
Delivery
At-home testing
Upper-arm collection
Clinician-Reviewed
Weight Loss

Wegovy FlexTouch Pen

A prescription-only injectable treatment used to support weight loss in adults with obesity or weight-related health risks, when clinically appropriate.

  • Once-weekly injection
  • Prescription-only medicine
  • Supplied following clinician approval
  • Discreet UK delivery
Clear
Start Your Consultation
  • UK Pharmacy
  • GPhC Registered
  • Discreet Delivery

Overview

Wegovy contains semaglutide, a medicine that helps regulate appetite and food intake. It is licensed in the UK for weight management in adults who meet clinical criteria and is used alongside dietary and lifestyle changes.

Supply of Wegovy is subject to an online assessment and video consultation, with approval by a UK-registered prescriber. Treatment is not suitable for everyone and is only supplied when it is considered safe and appropriate.

WHAT THE TEST MEASURES

Sildenafil 50mg may be suitable if you:

  • Are aged 18 or over
  • Have difficulty getting or maintaining an erection
  • Are not taking medicines that interact with sildenafil

It may not be suitable if you:

  • Take nitrates for heart conditions
  • Have certain heart, liver, or blood pressure conditions
  • Have been advised not to have sex for medical reasons

A pharmacist will review your answers before supply.

Learn more about this treatment

How Wegovy Works

Wegovy mimics a naturally occurring hormone involved in appetite regulation.

It may help by:

  • Acting on areas of the brain that control hunger
  • Increasing feelings of fullness after meals
  • Reducing appetite and overall calorie intake

These effects can support gradual, sustainable weight loss when combined with realistic lifestyle changes.

Wegovy is supplied as a single-use, pre-filled FlexTouch pen for injection under the skin (subcutaneous use). It is taken once weekly.

  • You can inject on any day of the week
  • Try to keep to the same day each week
  • Wegovy can be taken with or without food
  • Injection sites include the stomach, thigh, or upper arm. Sites should be rotated each week to reduce skin irritation.

Watch the manufacturer’s guide to learn more about using Wegovy: https://www.wegovy.co.uk/support-materials.html#video

Each pen includes full manufacturer instructions, which should be read carefully before first use. In general, weekly use involves:

  1. Check and prepare
     Confirm the pen is in date and at the correct dose. Wash your hands and choose a clean, dry area of skin.
  2. Attach a new needle
     Screw on a fresh needle and remove the protective caps. A new needle must be used for each injection.
  3. Administer the dose
     Hold the pen firmly against the skin and press the injection button. Keep the pen in place briefly to ensure the full dose is delivered.
  4. Dispose safely
     Remove the needle and place it in a sharps container or follow the disposal guidance provided.

If you are unsure about injection technique at any point, seek advice before continuing treatment.

Dosage and Dose Progression
Wegovy treatment follows a gradual dose-increase schedule to help your body adjust and reduce side effects.

Typical Dosing schedule


(May vary depending on clinical judgement)
  • Weeks 1–4: 0.25 mg once weekly
  • Weeks 5–8: 0.5 mg once weekly
  • Weeks 9–12: 1.0 mg once weekly
  • Weeks 13–16: 1.7 mg once weekly
  • Weeks 17–20: 2.4 mg once weekly
  • Week 21 onwards::
  • Continue 2.4 mg, or
  • Increase to 7.2 mg if advised by your clinician

Some people remain on 2.4 mg long-term if they are seeing good results and tolerating treatment well. Not everyone will progress to the highest dose.

If Wegovy is stopped, appetite may gradually return. Continued use is reviewed regularly to ensure treatment remains appropriate.

Like all medicines, Wegovy can cause side effects, particularly when starting treatment or increasing the dose.

Common side effects include:
  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Reduced appetite
  • Abdominal discomfort

Wegovy is not suitable for everyone and may not be appropriate if you have certain gastrointestinal, endocrine, or thyroid conditions, or if you are pregnant or breastfeeding.

Always read the patient information leaflet before use.

Patient Information Leaflet

For full prescribing and safety information, please read the official patient information leaflet.
Available via medicines.org.uk

Why Men Choose Vivamen

Clinician-led care

UK-registered Prescribers and Pharmacy

100% Discreet Service and Delivery

Designed Specifically for Men

Author Information

All of our medication and condition content is written by UK qualified pharmacists and doctors.

Authored by

Amit Raj

Superintendent Pharmacist

Reviewed by

XXXXXXXXXX

Medical Advisor / Pharmacist or Doctor
GPhC Number: 225377

Review Date:

XX March 2026

Next Review:

XX March 2027

Published on:

XX March 2026

Last Update:

XX March 2026

FREQUENTLY ASKED QUESTIONS

 Yes. Wegovy is licensed in the UK for chronic weight management in adults who meet specific clinical criteria.

Trust and Regulation

Supplied by a UK-registered pharmacy

Prescribed by UK-registered clinicians

Prescription-only medicines are supplied only if clinically appropriate

Fully compliant with GPhC standards for distance-selling pharmacies

Start A Consultation
  • Confidential
  • Clinician-led
  • Safety-focused

Overview

Plain, Discreet
Packaging
Tracked 24*7
Delivery
At-home testing
Upper-arm collection
Clinician-Reviewed
Weight Loss

Wegovy FlexTouch Pen

A prescription-only injectable treatment used to support weight loss in adults with obesity or weight-related health risks, when clinically appropriate.

  • Once-weekly injection
  • Prescription-only medicine
  • Supplied following clinician approval
  • Discreet UK delivery
Clear
Start Your Consultation
  • UK Pharmacy
  • GPhC Registered
  • Discreet Delivery

Overview

Wegovy contains semaglutide, a medicine that helps regulate appetite and food intake. It is licensed in the UK for weight management in adults who meet clinical criteria and is used alongside dietary and lifestyle changes.

Supply of Wegovy is subject to an online assessment and video consultation, with approval by a UK-registered prescriber. Treatment is not suitable for everyone and is only supplied when it is considered safe and appropriate.

WHAT THE TEST MEASURES

Sildenafil 50mg may be suitable if you:

  • Are aged 18 or over
  • Have difficulty getting or maintaining an erection
  • Are not taking medicines that interact with sildenafil

It may not be suitable if you:

  • Take nitrates for heart conditions
  • Have certain heart, liver, or blood pressure conditions
  • Have been advised not to have sex for medical reasons

A pharmacist will review your answers before supply.

Learn more about this treatment

How Wegovy Works

Wegovy mimics a naturally occurring hormone involved in appetite regulation.

It may help by:

  • Acting on areas of the brain that control hunger
  • Increasing feelings of fullness after meals
  • Reducing appetite and overall calorie intake

These effects can support gradual, sustainable weight loss when combined with realistic lifestyle changes.

Wegovy is supplied as a single-use, pre-filled FlexTouch pen for injection under the skin (subcutaneous use). It is taken once weekly.

  • You can inject on any day of the week
  • Try to keep to the same day each week
  • Wegovy can be taken with or without food
  • Injection sites include the stomach, thigh, or upper arm. Sites should be rotated each week to reduce skin irritation.

Watch the manufacturer’s guide to learn more about using Wegovy: https://www.wegovy.co.uk/support-materials.html#video

Each pen includes full manufacturer instructions, which should be read carefully before first use. In general, weekly use involves:

  1. Check and prepare
     Confirm the pen is in date and at the correct dose. Wash your hands and choose a clean, dry area of skin.
  2. Attach a new needle
     Screw on a fresh needle and remove the protective caps. A new needle must be used for each injection.
  3. Administer the dose
     Hold the pen firmly against the skin and press the injection button. Keep the pen in place briefly to ensure the full dose is delivered.
  4. Dispose safely
     Remove the needle and place it in a sharps container or follow the disposal guidance provided.

If you are unsure about injection technique at any point, seek advice before continuing treatment.

Dosage and Dose Progression
Wegovy treatment follows a gradual dose-increase schedule to help your body adjust and reduce side effects.

Typical Dosing schedule


(May vary depending on clinical judgement)
  • Weeks 1–4: 0.25 mg once weekly
  • Weeks 5–8: 0.5 mg once weekly
  • Weeks 9–12: 1.0 mg once weekly
  • Weeks 13–16: 1.7 mg once weekly
  • Weeks 17–20: 2.4 mg once weekly
  • Week 21 onwards::
  • Continue 2.4 mg, or
  • Increase to 7.2 mg if advised by your clinician

Some people remain on 2.4 mg long-term if they are seeing good results and tolerating treatment well. Not everyone will progress to the highest dose.

If Wegovy is stopped, appetite may gradually return. Continued use is reviewed regularly to ensure treatment remains appropriate.

Like all medicines, Wegovy can cause side effects, particularly when starting treatment or increasing the dose.

Common side effects include:
  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Reduced appetite
  • Abdominal discomfort

Wegovy is not suitable for everyone and may not be appropriate if you have certain gastrointestinal, endocrine, or thyroid conditions, or if you are pregnant or breastfeeding.

Always read the patient information leaflet before use.

Patient Information Leaflet

For full prescribing and safety information, please read the official patient information leaflet.
Available via medicines.org.uk

Why Men Choose Vivamen

Clinician-led care

UK-registered Prescribers and Pharmacy

100% Discreet Service and Delivery

Designed Specifically for Men

Author Information

All of our medication and condition content is written by UK qualified pharmacists and doctors.

Authored by

Amit Raj

Superintendent Pharmacist

Reviewed by

XXXXXXXXXX

Medical Advisor / Pharmacist or Doctor
GPhC Number: 225377

Review Date:

XX March 2026

Next Review:

XX March 2027

Published on:

XX March 2026

Last Update:

XX March 2026

FREQUENTLY ASKED QUESTIONS

 Yes. Wegovy is licensed in the UK for chronic weight management in adults who meet specific clinical criteria.

Trust and Regulation

Supplied by a UK-registered pharmacy

Prescribed by UK-registered clinicians

Prescription-only medicines are supplied only if clinically appropriate

Fully compliant with GPhC standards for distance-selling pharmacies

Start A Consultation
  • Confidential
  • Clinician-led
  • Safety-focused

Overview